Zeblok was formed in Dec 2014 with $350,000 in SAFE investor cash mid-2016. We have accumulated over $5 million in R&D toward development of a highly scalable, real-time and continuous edge-to-cloud sensor area network culminating in smart gait products and bio-informatics cloud for the healthcare industry.  Our primary customers are Clinical Trial Sponsors, Academic Research and the list is growing.  We plan to expand product reach this year as we position Zeblok’s first smart gait tracking/ electronic biomarker algorithm product as an approved medical device.